Hong Kong stocks fluctuate | BeiGene Ltd (06160.HK) opens nearly 7% higher, BCL2 inhibitor sotoclax second indication China application approved for listing.

According to the Intelligence Finance and Economics App, Beigene (06160.HK) opened nearly 7% higher, as of the time of writing, it is up 6.89% to 136.6 Hong Kong dollars, with a trading volume of 58.3555 million Hong Kong dollars.